United States· US:0781-3530_3a7a4ad7-90ca-4d84-92f1-c61032067deb
Cyclophosphamide
A cyclophosphamide product containing cyclophosphamide, registered in United States by Sandoz Inc. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cyclophosphamide is registered in 17 of 19 countries.
Countries holding a registration under ATC L01AA01 (cyclophosphamide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Cyclophosphamide · ATC L01AA01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cyclophosphamide costs, country by country.
Normalised to the WHO defined daily dose (0.25 g), the median price runs from $1.57 in France to $14.12 in Switzerland — a ×9.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cyclophosphamide · price per daily dose (0.25 g)
USD · FX 28 Sept 2026
- CH Switzerland$14.12
- IT Italy$1.58
- FR France$1.57
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CYCLOPHOSPHAMIDE
- Manufacturer
- Sandoz Inc
- Country
- United States (US)
- ATC code
- L01AA01
- ATC class
- Cyclophosphamide
- Defined daily dose
- 0.25 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1107813530101 VIAL, MULTI-DOSE in 1 CARTON (0781-3530-10) / 20 mL in 1 VIAL, MULTI-DOSE (0781-3530-80)
- ndc110781-3530-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
541 interactions on record for cyclophosphamide.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cyclophosphamide · interactions on record
541 records
- 34 severe
- 172 moderate
- 29 minor
- 304 info
Most severe, free to view
- Nalidixic acidJ01MB02severe
- CidofovirJ05AB12severe
- ThiotepaL01AC01severe
- CladribineL01BB04severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cyclophosphamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandCyclophosphamide SandozSandoz Polska Sp. z o.o.
- SwedenCyclophosphamide Sandoz 100 mg/ml Koncentrat till injektions-/infusionsvätska, lösningSandoz A/S
- United KingdomCyclophosphamide 1000mg/250ml in Sodium chloride 0.9% infusion bagsSpecial Order
- CzechiaCYCLOPHOSPHAMIDE ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- BelgiumCyclofosfamide Accord 1000 mgAccord Healthcare
- NetherlandsCyclofosfamide Accord 1000 mg, poeder voor oplossing voor injectie / infusieAccord Healthcare B.V.
- SpainCICLOFOSFAMIDA ACCORD 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIÓN EFGAccord Healthcare S.L.U.
- FinlandCyclophosphamide AccordAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Cyclophosphamid Sandoz, Endoxan
- Belgium · Cyclofosfamide Accord, Cyclophosphamide Hikma
- Bulgaria · Cyclophosphamide Sandoz, Ендоксан
- Cyprus · Cyclophosphamide Accord, Endoxan
- Czechia · Cyclophosphamide Accord, Endoxan
- Germany · Cyclophosphamid Accord, Cyclophosphamid Beta
- Denmark · Cyclophosphamide Accord, Cyclophosphamide Sandoz
- Estonia · Cyclophosphamide Accord, Endoxan
- Spain · Ciclofosfamida Accord, Ciclofosfamida Dr. Reddy
- Finland · Cyclophosphamide Accord, Sendoxan
- France · Cyclophosphamide Accord, Cyclophosphamide Reddy Pharma
- United Kingdom (Northern Ireland) · Cyclophosphamide Accord Healthcare, Cyclophosphamide Accord-Uk
- Greece · Endoxan
- Croatia · Ciklofosfamid Accord, Endoxan
- Hungary · Endoxan
- Ireland · Cyclophosphamide Monohydrate Seacross, Endoxana
- Iceland · Sendoxan
- Italy · Ciclofosfamide Accord, Cyclophosphamide Monohydrate Seacross
- Lithuania · Cyclophosphamide Accord Healthcare, Endoxan
- Luxembourg · Endoxan
- Latvia · Cyclophosphamide Accord, Endoxan
- Malta · Endoxana, Endoxana Injection
- Netherlands · Cyclofosfamide Accord, Cyclofosfamide Hikma
- Norway · Cyclophosphamide Accord, Sendoxan
- Poland · Cyclophosphamide Accord, Cyclophosphamide Sandoz
- Portugal · Ciclofosfamida Accord, Ciclofosfamida Hikma
- Romania · Ciclofosfamidă Accord, Ciclofosfamidă Dr. Reddy’s
- Sweden · Cyclophosphamide Accord, Cyclophosphamide Sandoz
- Slovenia · Endoxan
- Slovakia · Endoxan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7401e6f9-3247-47a3-880e-be87104cf12b GET /v1/drugs/7401e6f9-3247-47a3-880e-be87104cf12b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2000",
"substance": "CYCLOPHOSPHAMIDE",
"productndc": "0781-3530",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"dea_schedule": null,
"strength_unit": "mg/20mL",
"application_number": "NDA217150",
"marketing_category": "NDA"
}See everything about cyclophosphamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.